GET THE APP

IgA nephropathy in patients receiving a renal transplant
..

Journal of Nephrology & Therapeutics

ISSN: 2161-0959

Open Access

IgA nephropathy in patients receiving a renal transplant


9th International Conference on Dialysis and Renal Care

August 18-19, 2016 London, UK

Lemes-Canuto APPS, de Sandes-Freitas TV, Medina-Pestana JO and Mastroianni-Kirsztajn G

Hospital de Base de Brasilia, Brazil

Scientific Tracks Abstracts: J Nephrol Ther

Abstract :

Background: IgA nephropathy (IgAN) is the third most frequent cause of renal graft loss among patients with primary glomerulonephritis. Objectives: To assess clinical and laboratorial profile of patients with pre and/or post transplant IgAN, in addition to patient and graft survival in both groups. Design: Data from 146 patients who had received a renal transplant were retrospectively collected and were divided in two groups: group 1-patients with biopsy-documented IgAN as the underlying native kidney disease (n 1â?4 128); group 2-patients who developed post-transplant IgAN independent of the underlying disease (n 1â?4 18). Participants: Patients submitted to renal transplantation (1998â??2010) with pre and/or post transplant IgAN. Measurements: Clinical and laboratorial evaluation of renal function of 146 post transplant IgAN patients. Results: Recipients and deceased donors exhibited a higher degree of HLA compatibility (1.0 vs. 2.5 mismatches for groups 1 and 2, respectively). The main post-transplant IgAN presentation was haematuria associated with non-nephrotic proteinuria (44.4%). A histological pattern of focal segmental glomerulosclerosis was observed in 59.2% of biopsy samples. The 10-year patient survival was 93.5% in group 1 and 100% in group 2, and the graft survival rates were 58.5 and 87.2%, respectively. Conclusion: The rate of post-transplant IgA diagnosis in our case series was 11%, and IgAN was diagnosed late in the course of transplantation. In most cases, IgAN manifested as haematuria and non-nephrotic proteinuria, without renal graft dysfunction, and this picture might explain late indication of graft biopsies. The 10-year patient survival rates were excellent.

Biography :

Lemes-Canuto APPS has completed her graduation in Medicine at the University of Ribeirao Preto/UNAERP (2003). She has a specialist title in Nephrology by the Brazilian Society of Nephrology, and Master’s degree in Health Sciences by the Federal University of Sao Paulo/UNIFESP, in the area of Nephrology/Glomerulopathy. At present, she works as a Nephrologist in an outpatient clinic in the area of Glomerulopathies in Federal District and in the Clinic of Uraemia in the Hospital of the University of Brasilia/ UNB-HUB.

Email: [email protected]

Google scholar citation report
Citations: 647

Journal of Nephrology & Therapeutics received 647 citations as per google scholar report

Journal of Nephrology & Therapeutics peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward